chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Insomnia, Menopausal symptoms, Middle insomnia, Night sweats
Clinical narrative: I feel like I am in menopause again; difficulty getting back to sleep; hot flashes; night sweats; wake up during the night; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to sulfa and latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included aciclovir (ACYCLOVIR), magnesium glycinate (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and multi (MANUFACTURER UNKNOWN);all from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 18:30 the patient reported that she feels like she was in menopause again. she woke up during the night or early in the morning and had difficulty getting back to sleep, she was also having hot flashes and night sweats. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events she feels like she was in menopause again, she woke up during the night or early in the morning and had difficulty getting back to sleep, she was also having hot flashes and night sweat were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstrual disorder, Menstruation irregular, Polymenorrhoea
Clinical narrative: Very heavy and unusually early menstrual cycle (by 5 days); Very heavy and unusually early menstrual cycle (by 5 days); Also shorter in duration ( only 3 days instead of 5); It also is much thinner blood than usual; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration on 19Apr2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 01May2021, the patient experienced very heavy and unusually early menstrual cycle (by 5 days) and also shorter in duration (only 3 days instead of 5). It also was much thinner blood than usual. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very heavy and unusually early menstrual cycle (by 5 days), also shorter in duration (only 3 days instead of 5) and it also was much thinner blood than usual was recovered on an unknown date in May2021.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Ear pain, Headache, Nausea
Clinical narrative: Chills; High fever; Body aches; Splitting headache; Nausea; Sinus drainage; Earache; Stomach ache; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 15:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, a stroke in 2019 and allergy to penicillin and some antibiotics. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), hydrochlorothiazide (HYDRODIURIL) and acetylsalicylic acid (ASPIRIN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 03:30, the patient experienced chills, high fever, body aches, splitting headache, nausea, sinus drainage, ear ache and stomach ache. On an unknown date in May2021, at day 10, the patient still had stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, high fever, body aches, splitting headache, nausea, sinus drainage and ear ache was resolving while stomach ache was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paranasal sinus hypersecretion, Pyrexia
Clinical narrative: Chills; High fever; Body aches; Splitting headache; Nausea; Sinus drainage; Earache; Stomach ache; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 15:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, a stroke in 2019 and allergy to penicillin and some antibiotics. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), hydrochlorothiazide (HYDRODIURIL) and acetylsalicylic acid (ASPIRIN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 03:30, the patient experienced chills, high fever, body aches, splitting headache, nausea, sinus drainage, ear ache and stomach ache. On an unknown date in May2021, at day 10, the patient still had stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, high fever, body aches, splitting headache, nausea, sinus drainage and ear ache was resolving while stomach ache was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Confusional state, Fatigue, Feeling abnormal, Nausea
Clinical narrative: Brain fog 24 hours after vaccination; waves of nausea; Very tired 20 hours after vaccination; Unable to keep eyes open 20 hours after vaccination; Very confused upon waking up 18 hours after vaccination. Extreme confusion 24 hours after vaccination; Very sore arm 4 hours after vaccination, lasted all second day; Very sore arm with burning sensation 4 hours after vaccination, lasted all second day; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 03May2021 at 12:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac, hypothyroidism, attention deficit hyperactivity disorder (ADHD), depression, obsessive-compulsive disorder (OCD), anxiety and allergy to strawberries. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol; etynodiol diacetate (KELNOR) from an unknown date indicated for birth control, lisdexamfetamine mesilate (VYVANSE) and levothyroxine (MANUFACTURER UNKNOWN), both from unknown date for unknown indication. On 03May2021 at 16:00, 4 hours after vaccination, the patient experienced very sore arm with burning sensation, lasted all second day. On 04May2021 at 08:00, 18 hours after vaccination, the patient was very confused upon waking up. On 04May2021 at 10:00, 20 hours after vaccination, the patient was very tired, unable to keep eyes open. On 04May2021 at 14:00, 24 hours after vaccination, the patient experienced, brain fog, extreme confusion and waves of nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore arm with burning sensation, very confused upon waking up, very tired, unable to keep eyes open, brain fog, extreme confusion and waves of nausea was not resolved at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Somnolence
Clinical narrative: Brain fog 24 hours after vaccination; waves of nausea; Very tired 20 hours after vaccination; Unable to keep eyes open 20 hours after vaccination; Very confused upon waking up 18 hours after vaccination. Extreme confusion 24 hours after vaccination; Very sore arm 4 hours after vaccination, lasted all second day; Very sore arm with burning sensation 4 hours after vaccination, lasted all second day; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 03May2021 at 12:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac, hypothyroidism, attention deficit hyperactivity disorder (ADHD), depression, obsessive-compulsive disorder (OCD), anxiety and allergy to strawberries. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol; etynodiol diacetate (KELNOR) from an unknown date indicated for birth control, lisdexamfetamine mesilate (VYVANSE) and levothyroxine (MANUFACTURER UNKNOWN), both from unknown date for unknown indication. On 03May2021 at 16:00, 4 hours after vaccination, the patient experienced very sore arm with burning sensation, lasted all second day. On 04May2021 at 08:00, 18 hours after vaccination, the patient was very confused upon waking up. On 04May2021 at 10:00, 20 hours after vaccination, the patient was very tired, unable to keep eyes open. On 04May2021 at 14:00, 24 hours after vaccination, the patient experienced, brain fog, extreme confusion and waves of nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore arm with burning sensation, very confused upon waking up, very tired, unable to keep eyes open, brain fog, extreme confusion and waves of nausea was not resolved at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Dizziness, Fatigue, Headache
Clinical narrative: Dizziness; Ringing in the ears; Headache; Nausea; Slight fever (100.3); Wheezing; Excessive fatigue; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 03May2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, high blood pressure (HBP),hypothyroidism, migraine, lymphedema, chronic pain, artificial joints- total knee replacement (TKR) both knees, both hands/thumbs; spinal fusion/plates/screws/bone at C5 &C7, hysterectomy and known allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications for HBP, migraines, anxiety and pain within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took nitrofurantoin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 12Apr2021 at 09:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 06:30, the patient experienced slight fever (100.3). Her regular temperature was usually around 96.5. She also experienced wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea. On the same day, the patient underwent body temperature test and the result was 100.3 (unit unspecified). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with   ipratropium bromide (ATROVENT NEBULIZER), salbutamol (VENTOLIN), paracetamol (TYLENOL) and ondansetron (ZOFRAN) . Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's slight fever (100.3), wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Tinnitus, Wheezing
Clinical narrative: Dizziness; Ringing in the ears; Headache; Nausea; Slight fever (100.3); Wheezing; Excessive fatigue; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 03May2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, high blood pressure (HBP),hypothyroidism, migraine, lymphedema, chronic pain, artificial joints- total knee replacement (TKR) both knees, both hands/thumbs; spinal fusion/plates/screws/bone at C5 &C7, hysterectomy and known allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications for HBP, migraines, anxiety and pain within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took nitrofurantoin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 12Apr2021 at 09:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 06:30, the patient experienced slight fever (100.3). Her regular temperature was usually around 96.5. She also experienced wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea. On the same day, the patient underwent body temperature test and the result was 100.3 (unit unspecified). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with   ipratropium bromide (ATROVENT NEBULIZER), salbutamol (VENTOLIN), paracetamol (TYLENOL) and ondansetron (ZOFRAN) . Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's slight fever (100.3), wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Nodule, Vaccination site mass
Clinical narrative: Painful knot in left arm that moved locations: from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm.; Painful knot in left arm that moved locations: from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm right on 19Mar2021 at 12:00(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously took PERCOCET on an unknown date for unknown indication and experienced drug allergy. On 20Mar2021, the patient experienced painful knot in left arm that moved locations from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events painful knot in left arm that moved locations, from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, SARS-CoV-2 test
Clinical narrative: Increased arthritic pain in fingers but not in the finger joints; This is a spontaneous report received from a contactable consumer (patient) reported for himself. A 66-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6208, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 11Mar2021 at 15:00 pm age at vaccination was 66 years as dose 2, single for COVID-19 immunization. The patient's medical history included type II diabetes from an unknown date. Concomitant medication the patient received within 2 weeks of vaccination included VYVANSE taken for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6201, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 10Feb2021 at 14:30 pm age at vaccination was 66 years as dose 1, single for COVID-19 immunization. The patient previously took codeine and egg based flu shots and experienced known allergies to it. The facility where the most recent COVID-19 vaccine was administered was Hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 12Mar2021 at 13:00 pm, the patient experienced increased arthritic pain in fingers but not in the finger joints. The patient received treatment with Advil for the event. The patient underwent lab test which included SARS-CoV-2 test negative on an unspecified date. The device date was reported as 08May2021. The outcome of the event was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pain in extremity, Pyrexia, SARS-CoV-2 test
Clinical narrative: Body aches; Fever/Had a body temperature of 99.9F; Just arm was a little sore; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number was not reported), via an unspecified route of administration on 06May2021 at the age of 63-year-old) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number was not reported), via an unspecified route of administration on 15Apr2021 as single dose for COVID-19 immunization and she had lost her voice and had hoarseness. The patient got second dose of the Pfizer vaccine on Thursday afternoon (06May2021). And she did find as far as side effects that day and the next day, just arm was a little sore. But now today (08May2021) she woke up feeling kind of body achy, she took her temperature, and it's 99.9F, for her that's high because normally her temperature only went like 97 point something. So she was wondering and read the fact sheet that given to her with the vaccine but she did not see for it said how long after one get the vaccine, get the side effects could possibly come up. So she was wondering if it's normal, but still, stated, she had a fever. She wanted to know how long usually side effects last. The patient underwent lab tests and procedures which included rapid test negative on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic taste in mouth right after the shot; This is a spontaneous report from a contactable healthcare professional, the patient. A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 03May2021 at 16:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient received other vaccine within 4 weeks prior to COVID-19 vaccination which included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient previously received METOCLPRAMIDE and experienced drug allergy. On 03May2021 at 16:15 (reported as 04:15), the patient experienced metallic taste in mouth right after the shot. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event metallic taste in mouth right after the shot was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Dizziness, Headache
Clinical narrative: Sore arm; Severe headache; Body/joint aches; Body/joint aches; nausea; Dizziness; Chills; Sweating; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 03May2021 at 13:45 at the age of 43-years-old as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), hashimoto's disease, allergy to gold, cobalt, nickel, disperse blue dye, and adhesives. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included unspecified birth control pill from unknown date and unknown if ongoing, also ATORVASTATIN and SYNTHYROID, both for unknown indication from unknown date and unknown if ongoing. The patient previously took THIMEROSAL and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 12Apr2021 at 13:45 at the age of 43-years-old as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 21:00, the patient experienced sore arm, severe headache, body and joint aches, nausea, dizziness, chills, sweating, and diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, severe headache, body and joint aches, nausea, dizziness, chills, sweating, and diarrhea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nausea, Pain, Pain in extremity
Clinical narrative: Sore arm; Severe headache; Body/joint aches; Body/joint aches; nausea; Dizziness; Chills; Sweating; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 03May2021 at 13:45 at the age of 43-years-old as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), hashimoto's disease, allergy to gold, cobalt, nickel, disperse blue dye, and adhesives. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included unspecified birth control pill from unknown date and unknown if ongoing, also ATORVASTATIN and SYNTHYROID, both for unknown indication from unknown date and unknown if ongoing. The patient previously took THIMEROSAL and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 12Apr2021 at 13:45 at the age of 43-years-old as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 21:00, the patient experienced sore arm, severe headache, body and joint aches, nausea, dizziness, chills, sweating, and diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, severe headache, body and joint aches, nausea, dizziness, chills, sweating, and diarrhea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Hypersomnia, Pain, Painful respiration
Clinical narrative: Diarrhea; Vomiting; Headache; Body aches; Slept all day; Pain when breathing; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 02May2021 at 08:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, allergy to sulphate drugs and eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control medications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 11Apr2021 at 13:15 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. On 03May2021, at 05:00, the patient experienced diarrhea, vomiting, headache, body aches, slept all day and pain when breathing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, vomiting, headache, body aches, slept all day and pain when breathing was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Diarrhea; Vomiting; Headache; Body aches; Slept all day; Pain when breathing; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 02May2021 at 08:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, allergy to sulphate drugs and eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control medications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 11Apr2021 at 13:15 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. On 03May2021, at 05:00, the patient experienced diarrhea, vomiting, headache, body aches, slept all day and pain when breathing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, vomiting, headache, body aches, slept all day and pain when breathing was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams
Clinical narrative: Weird vivid dreams now for 5 nights; This is a spontaneous report from a contactable nurse, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 30Apr2021 at 10:30(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included butalbital, caffeine, paracetamol (FIORICET) for an unknown indication from an unknown date and unknown if ongoing. The patient previously took ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 30Apr2021, the patient experienced weird vivid dreams now for 5 nights(as reported). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event weird vivid dreams was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Discomfort, Groin pain, Lymphadenopathy
Clinical narrative: Swollen supraclavicular lymph node on left side of neck, above collar bone; Also some mild pain, discomfort in groin area and underarms; Also some mild pain, discomfort in groin area and underarms; Also some mild pain, discomfort in groin area and underarms; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, hashimoto's disease, anxiety and gluten intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. On 06Apr2021, the patient experienced swollen supraclavicular lymph node on left side of neck, above collar bone and also had some mild pain, discomfort in groin area and underarms. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen supraclavicular lymph node on left side of neck, above collar bone, some mild pain, discomfort in groin area and underarms was recovered on an unknown date in 2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 20Apr2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing Ears; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 15Apr2021 at 18:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol succinate (METOPROLOL) started on an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 25Mar2021 at 18:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced ringing ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing ears was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Lymph node pain, Lymphadenopathy, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: left arm still sore on a 3 inch diameter from where shot was given- now 3 and half weeks later; Under arm lymph swollen on left side; Under arm lymph swollen on left side, tender; Inappropriate schedule of vaccine administered to Dose 1: 30Mar2021; Dose 2: 10Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 10Apr2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included Epstein barr active, Hashimoto's disease and sulfonamide allergy(sulfa drugs). Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications included low dose naltrexone (MANUFACTURER UNKNOWN) and glycerine monolaurate (MONOLAURIN); both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 30Mar2021 at 14:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021, the patient's left arm was still sore on a 3-inch diameter from where shot was given even after 3 and half weeks later and the patient's under arm lymph was swollen on left side and was tender. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. On 16Apr2021, the patient underwent Nasal swab, SARS CoV-2 test and the result was negative. The clinical outcome of the events left arm still sore, under arm lymph swollen on left side and tender were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pain in extremity
Clinical narrative: Body aches all over and a headache; Body aches all over and a headache; Even "my" fingers and toes were hurting; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 04May2021 at 13:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included one a day prenatal vitamins (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 13:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 01:15, about 12 hours after shot, the patient experienced body aches all over and a headache and even the patient's fingers and toes were hurting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches all over and a headache and even "my" fingers and toes were hurting was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Tinnitus
Clinical narrative: migraine headaches; Ringing in the ears since after 1st dose and has not stopped and not getting migraine headaches; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an intramuscular route of administration in the arm left on 29Dec2020 as a single dose for COVID-19 immunisation. Medical history included contrast dye allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN XL) and pantoprazole sodium sesquihydrate (PROTONIX); all on an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Dec2020, the patient experienced ringing in the ears since after 1st dose and has not stopped and now started getting migraine headaches. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in the ears and migraine headaches was not recovered at the time of this report. The patient received second dose of BNT162b2 (COMIRNATY; Lot number: EL3246), via an unspecified route of administration in the arm left on an unknown date as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Menstruation irregular
Clinical narrative: Dizziness from time to time; Irregular menstural; Headaches; This is a spontaneous report from a contactable healthcare professional, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration on an unknown date (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021, the patient experienced dizziness from time to time, irregular menstrual and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, irregular menstrual and headaches were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Lymphadenopathy
Clinical narrative: Swollen lymph nodes in armpit; Fatigue; Painful joints; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration on an unknown date in 2021 (at the age of 37-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced swollen lymph nodes in armpit, fatigue and painful joints. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes in armpit, fatigue and painful joints were resolving at the time of report.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Dizziness
Clinical narrative: Dizziness; Diarrhea; Painful joints; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 at 10:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included vasculitis, heart disease, stage three kidney disease and allergy to sulpha drugs. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 09:00 as a single dose for COVID-19 immunisation. On 05May2021 at 00:00, the patient experienced dizziness, diarrhea and painful joints. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, diarrhea and painful joints was not resolved at the time of the report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.